10 Million ABHA IDs in Just 2 Years: Industry Experts Discuss the Role of Ayushman Bharat Digital Mission in Mankind Pharma's Docflix Exclusive 5W1H Podcast

Published On 2024-04-03 05:23 GMT   |   Update On 2024-04-03 05:32 GMT

Mankind Pharma's OTT platform for healthcare professionals, Docflix, tackles the transformative Ayushman Bharat Digital Mission (ABDM) in its recent episode of the exclusive podcast series, 5W1H. The episode features a distinguished panel of experts including Kiran Anandampillai, Advisor on Technology at the National Health Authority; Dr. Neelesh Kapoor, Diabetologist and founder of...

Login or Register to read the full article

Mankind Pharma's OTT platform for healthcare professionals, Docflix, tackles the transformative Ayushman Bharat Digital Mission (ABDM) in its recent episode of the exclusive podcast series, 5W1H. The episode features a distinguished panel of experts including Kiran Anandampillai, Advisor on Technology at the National Health Authority; Dr. Neelesh Kapoor, Diabetologist and founder of Eka Care; and Dr. Pankaj Kumar, Orthopedician. Rinkesh Shah, Head of Digital Marketing at Mankind Pharma, anchors the discussion.

Please click on the link to access the podcast: https://bit.ly/3xm6gvt

Full View

The episode provides a comprehensive analysis of ABDM's role in bolstering the country's digital health infrastructure, fostering collaboration between startups and governmental initiatives, and elucidating the significance of digitized health records through the ABHA platform. ABDM's core objective is to democratize access to healthcare technology by dismantling market monopolies and establishing robust architectural frameworks. Through ABDM, healthcare providers can leverage personalized data points for patients, facilitated by a suite of Personal Health Record (PHR) apps, thus enhancing patient literacy and expediting processes like insurance claims settlement. Notably, the incentivization of healthcare professionals under ABDM presents a lucrative opportunity, with doctors now eligible to earn up to Rs. 4 Crores by linking health records to ABHA after the initial 100 records.

In the episode, Mr. Kiran Anandampillai, Advisor on Technology at the National Health Authority shared, “The government created ABHA to digitize patient health records and to identify patients, thereby enhancing interoperability among hospitals digitally. Its official website lists partners for various end customers, along with contact information for demos and setup assistance. Additionally, there are approximately seven PHR apps available for patients. NHAI and IRDAI have proposed NHCE (National Health Claims Exchange) to streamline insurance claims, with over 22 TPAs already integrated. ABDM also features new technology for teleconsultation through the UHI (Unified Health Interface), allowing doctors and patients to use compatible apps.”

During the interaction, Dr. Neelesh Kapoor, Diabetologist and founder of Eka Care emphasized, “Technology is a great equalizer; it does not differentiate between people. In India, if we look at structural problems like availability, affordability, and access, all can be addressed by technology. It ensures good care for people residing in the remotest areas of the country or those belonging to marginalized communities in India.”

Through this dedicated OTT platform for healthcare professionals, Mankind Pharma aims to foster a culture of knowledge-sharing and awareness-building within the medical community. By facilitating discussions on transformative initiatives like the Ayushman Bharat Digital Mission (ABDM), Mankind Pharma endeavors to empower healthcare professionals with the latest insights and advancements in the field. Through Docflix®, Mankind Pharma wants to catalyze positive change in clinical practices, enhance patient care, and drive progress in the insurance sector, ultimately contributing to the holistic development of India's healthcare ecosystem.

Please click on the link to access the podcast: https://bit.ly/3xm6gvt

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News